Finally, by taking advantage of cancer patient-specific transcriptomic, proteomic and phosphoproteomic data stored in different databases, we report that while CDK1 protein is clearly upregulated in tumours, its activity seems to be suppressed, as revealed by its phosphorylation status on regulatory sites. Here, CDK1 is linked to neoplasm.